Bgm (BGM) Goodwill & Intangibles (2019 - 2025)
Bgm's (BGM) quarterly Goodwill & Intangibles came in at $355.3 million in Q3 2025, up 7727.93% year-on-year from $4.5 million in Q3 2024, and up 154.12% on a QoQ basis from $139.8 million in Q1 2025.
Bgm (BGM) Goodwill & Intangibles (2019 - 2025) Analysis & Trends
Bgm (BGM) has 7 years of Goodwill & Intangibles data on file, last reported at $355.3 million in Q3 2025.
- On a quarterly basis, Goodwill & Intangibles rose 7727.93% year-over-year to $355.3 million in Q3 2025; TTM through Sep 2025 was $355.3 million, a 7727.93% increase from a year earlier, with the FY2025 full-year figure at $355.3 million, up 7727.93% from the prior year.
- Goodwill & Intangibles for Q3 2025 stood at $355.3 million, up from $139.8 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for BGM reached as high as $3679.8 billion in Q1 2023 and fell as low as $1.7 million in Q3 2022.
- Historically, Goodwill & Intangibles has averaged $750.5 billion across 5 years, with a median of $72.2 million in 2024.
- Across the five-year window, Goodwill & Intangibles slumped 100.0% in 2024 and jumped 7727.93% in 2025, its largest moves.
- Year by year, Goodwill & Intangibles stood at $1.9 million in 2021, then declined by 10.43% to $1.7 million in 2022, then soared by 98.25% to $3.4 million in 2023, then soared by 32.59% to $4.5 million in 2024, then soared by 7727.93% to $355.3 million in 2025.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $355.3 million in Q3 2025, $139.8 million in Q1 2025, and $4.5 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Bgm | 33.55 Mn | 23.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 355.34 Mn |
| Mar 31, 2025 | 139.83 Mn |
| Sep 30, 2024 | 4.54 Mn |
| Mar 31, 2024 | 3.42 Mn |
| Sep 30, 2023 | 3.42 Mn |
| Mar 31, 2023 | 3,679.79 Bn |
| Sep 30, 2022 | 1.73 Mn |
| Mar 31, 2022 | 1,899.18 Bn |
| Sep 30, 2021 | 1.93 Mn |
| Mar 31, 2021 | 1,925.97 Bn |
| Sep 30, 2020 | 1.88 Mn |
| Sep 30, 2019 | 1.83 Mn |